Tetra Radar · FDA Approvals · Decision date
Anaphylm: FDA decision date
Aquestive Therapeutics Inc (AQST) · 16 March 2027
Aquestive Therapeutics Announces FDA Acceptance of Anaphylm™ NDA Resubmission and PDUFA Goal Date of March 16, 2027.
Source: 8-K of 15 October 2026
The decision is pending.
Aquestive Therapeutics Inc on Tetra Radar
A PDUFA date is the date by which the FDA has said it will decide on an application. Dates can move, and a decision is not an approval. Tetra Radar observes public information for research purposes. It does not provide investment advice.